Works matching IS 15525260 AND DT 2010 AND VI 6 AND IP 5
Results: 12
Alzheimer's Association Update September 2010
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. 429, doi. 10.1016/j.jalz.2010.08.227
- Publication type:
- Article
Web-based application to project the burden of Alzheimer's disease
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. 425, doi. 10.1016/j.jalz.2010.01.014
- By:
- Publication type:
- Article
Alzheimer's disease, a multifactorial disorder seeking multitherapies
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Influence of apolipoprotein E ɛ4 on rates of cognitive and functional decline in mild cognitive impairment
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. 412, doi. 10.1016/j.jalz.2009.12.003
- By:
- Publication type:
- Article
Cerebral atrophy, apolipoprotein E ɛ4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. 404, doi. 10.1016/j.jalz.2010.02.003
- By:
- Publication type:
- Article
White matter is altered with parental family history of Alzheimer's disease
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. 394, doi. 10.1016/j.jalz.2009.11.003
- By:
- Publication type:
- Article
Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. 386, doi. 10.1016/j.jalz.2009.12.004
- By:
- Publication type:
- Article
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. 378, doi. 10.1016/j.jalz.2010.03.014
- By:
- Publication type:
- Article
Requiring an amyloid-β<sub>1-42</sub> biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. 367, doi. 10.1016/j.jalz.2010.07.004
- By:
- Publication type:
- Article
Medical and Scientific Advisory Council
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. A5, doi. 10.1016/S1552-5260(10)02428-3
- Publication type:
- Article
Editorial Board
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. A4, doi. 10.1016/S1552-5260(10)02427-1
- Publication type:
- Article
Subscriber Information
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 5, p. A1, doi. 10.1016/s1552-5260(10)02155-2
- Publication type:
- Article